Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-15

Clinical Trial Update: Chlorhexidine Gluconate Solution at 0.125% vs Placebo for the Healing of Grade IIB Ulcers of Diabetic Foot [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing 0.125% chlorhexidine gluconate solution to placebo for healing grade IIB diabetic foot ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorhexidine gluconate 0.125% solution (chlorhexidine gluconate)

Snippet

Sponsor: Universidad de Guanajuato | Conditions: Diabetic Foot | Phase 4 | Status: UNKNOWN